NCT01796938

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects

Open, Non-randomized, Sequential Group Comparison to Investigate the Pharmacokinetics, Safety, and Tolerability of 100 mg SPM 927 in Male and Female Subjects With Renal Impairment Including Subjects Requiring Dialysis Compared With Male and Female Healthy Subjects Following Single-dose Administration

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: UCB BIOSCIENCES GmbH · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

To investigate the Pharmacokinetics (PK) of oral administered Lacosamide in renal impaired subjects and healthy subjects.

Conditions

• Healthy
• Renal Impairment

Interventions

Type	Name	Description
DRUG	Lacosamide tablet	Single dose of 100 mg Lacosamide tablet

Timeline

• Start date: 2004-06-01
• Primary completion: 2004-11-01
• Completion: 2004-11-01
• First posted: 2013-02-22
• Last updated: 2014-10-20

Locations

2 sites across 1 country: Germany